Diabetes, heart disease raise cardiac toxicity risk for some

08/10/2011 | CardiovascularBusiness.com

Diabetes and heart disease may elevate the risk of cardiac toxicity in elderly breast cancer patients who were on trastuzumab treatment, a study in the Annals of Oncology found. The findings underscore the importance of intensive observation for early signs of the condition and cardiac function in patients, experts said.

View Full Article in:

CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY